5,000-Patient study aims to unlock sarcoidosis mysteries
NCT ID NCT06576505
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why sarcoidosis affects people differently—some get better, others develop long-term lung damage. Researchers will analyze genes, immune cells, and gut bacteria from 5,000 participants, including healthy volunteers. The goal is to find markers that predict disease course and treatment response, paving the way for personalized care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, Stockholm County, 171 76, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Can immune profiling unlock the hidden stages of tuberculosis?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Home devices may spot lung flare-ups before they become emergencies
- Massive study tracks lung disease progression in 4,000 patients
- 5,000 patients to help unlock secrets of inflammatory heart disease